For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.
The primary mission of the Molecular Pathology Laboratory at NewYork-Presbyterian/Weill Cornell Medicine is to provide the best clinical molecular diagnostic services for the clinicians and pathologists providing care to patients at NewYork-Presbyterian. Since its inception, this laboratory has been developing and performing state-of-the-art molecular-based tests to aid in the diagnosis and management of infectious disease, genetic disorders, solid tumor malignancies and monitoring transplant, working closely with clinicians, pathologists and health care professionals. The laboratory is directed by Hanna Rennert, PhD, FACMG, with ten staff members (a PhD technical specialist, supervisor and laboratory technologists). The laboratory is CLIA-certified and accredited by New York State Department of Health and the College of American Pathologists.
The Molecular Pathology Laboratory
Test Menu
Oncology test menu:
- Targeted EGFR exon 18-21 mutation analysis
- Microsatellite instability (MSI) analysis
- MGMT methylation analysis
- Cancer Gene Mutation Panel (50 Gene NGS Assay)
Genetic Test Menu:
- Thrombophilia mutation analysis
- Cystic Fibrosis (CF) testing
Transplant Test Menu:
- Bone marrow engraftment (BME) analysis (Chimerism Testing)
Infectious Disease Test menu:
- Human immunodeficiency virus 1 (HIV-1) viral load
- Human immunodeficiency virus 1 (HIV-1) genotyping for drug resistance (NRTI, NNRTI and PI mutations)
- Hepatitis C viral (HCV) load
- Hepatitis B (HBV) viral load
- Cytomegalovirus (CMV) viral load
- Epstein-Barr virus (EBV) viral load
- Human herpes virus 6 (HHV-6 A and B) viral load
- BK virus (BKV) viral load
- Adenovirus (AdV) viral load
- Toxoplasma gondii parasite load
Detailed testing information for the Molecular Path tests is available on the NYP Infornet.
